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p27Cyclin-dependent kinase 2 (Cdk2) is dispensable for mitotic cell cycle progression and Cdk2 knockout mice are
viable due to the compensatory functions of other Cdks. In order to assess the role of Cdk2 under limiting condi-
tions, we used Skp2 knockout mice that exhibit increased levels of Cdk inhibitor, p27Kip1, which is able to inhibit
Cdk2 and Cdk1. Knockdown of Cdk2 abrogated proliferation of Skp2−/−mouse embryonic ﬁbroblasts, encourag-
ing us to generate Cdk2−/−Skp2−/− double knockout mice. Cdk2−/−Skp2−/− double knockout mice are viable
and display similar phenotypes as Cdk2−/− and Skp2−/− mice. Unexpectedly, ﬁbroblasts generated from
Cdk2−/−Skp2−/− double knockout mice proliferated at normal rates. The increased stability of p27 observed
in Skp2−/− MEFs was not observed in Cdk2−/−Skp2−/− double knockout ﬁbroblasts indicating that in the
absence of Cdk2, p27 is regulated by Skp2-independent mechanisms. Ablation of other ubiquitin ligases for
p27 such as KPC1, DDB1, and Pirh2 did not restore stability of p27 in Cdk2−/−Skp2−/− MEFs. Our ﬁndings
point towards novel and alternate pathways for p27 regulation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cdk2 in partnership with E and A-type cyclins, promotes the G1/S
phase transition and drives cells through S phase. These events can
occur independently of Cdk2, since Cdk2 knockout mice are viable and
Cdk2−/− cells progress through the cell cycle [1,2]. In the absence of
Cdk2, Cdk1/cyclin E complexes regulate the G1/S phase transition
[3,4]. Unexpectedly, Cdk2 knockout mice are sterile, indicating an
essential role for Cdk2 in meiosis; while compensation by other Cdks
renders Cdk2 dispensable for mitotic progression [1,2].
Cdk2 is the main target of the cyclin-dependent kinase inhibitor
p27Kip1, although p27 binds also to Cdk4 and Cdk1 [5–9]. The loss of
p27 leads to increased cell proliferation and p27 knockout mice are
bigger in size with enlarged organs and develop pituitary tumorsd Cell Biology (IMCB), A*STAR
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pan.
ights reserved.[10–12]. Although Cdk2 activity is elevated in p27−/− tissues, the dele-
tion of Cdk2 in p27−/−mice does not rescue the aberrant phenotypes
[3]. Tissues from p27−/−Cdk2−/− double knockout mice exhibit elevat-
ed Cdk1 activity that may compensate for the loss of Cdk2 function.
The essential role of p27 in growth control is further revealed in the
Skp2−/−p27−/− double knockout mice [13]. Skp2 is an F-box protein
and component of the Skp1-Cullin-F-box protein (SCF) ubiquitin ligase
that mediates the ubiquitination and subsequent degradation of p27
[14–17]. While Skp2 knockout mice are viable, Skp2−/− cells exhibit
severe proliferation defects and p27 accumulates to high levels [18]. In
spite of regulation of several other substrates by Skp2 [19–25], the dele-
tion of p27 alone rescues the proliferation defects in Skp2−/−mice [13].
Since compensatory Cdk activities in Cdk2−/− mice obscures the
role of Cdk2, we decided to delete Skp2 in Cdk2−/−mice, with the pre-
mise that high levels of p27 in Skp2−/− tissues would effectively sup-
press the activities of other Cdks, particularly Cdk1 that is known to
drive cells through the S phase in the absence of Cdk2 [3,4]. Here we
report that Cdk2−/−Skp2−/−mice are viable and exhibit a combination
of phenotypes seen in Skp2−/− and Cdk2−/−mice such as sterility and
reduced body size. However, the enhanced p27 stability that was
observed in Skp2−/− cells was not seen in Cdk2−/−Skp2−/− cells, indi-
cating alternate mechanisms of p27 regulation in the absence of Skp2
and Cdk2.
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in Skp2−/− cells where proteolysis of p27 occurs normally in the
cytoplasm at the G0/G1 transition [26]. KPC (Kip1 ubiquitination-
promoting complex) was identiﬁed as the cytosolic ubiquitin ligase
complex that mediates Skp2-independent p27 ubiquitination fol-
lowing p27 nuclear export in the G1 phase, while Skp2 has been
suggested to mediate nuclear ubiquitination of p27 in S and G2
phase [21,27]. Interestingly, the phosphorylation of p27 at Thr187
is essential for Skp2-mediated degradation, but is not required for
KPC-mediated ubiquitination of p27. The regulation of p27 by
KPC1 occurs in a Ser10 phosphorylation-dependent manner that reg-
ulates nuclear export of p27 [21]. Two other ubiquitin ligases, Pirh2
and the Cul4A-DDB1 complex have been implicated in the regulation
of p27. Pirh2 is reported to ubiquitinate and promote proteasomal
degradation of p27 at the G1/S transition [28]. DDB1, a subunit of the
damaged-DNA binding protein DDB, functions as an adaptor for
Cul4A, a member of the cullin family of E3 ubiquitin ligases [29–31].
While Pirh2-mediated degradation of p27 appears to be independent
of Skp2, Cul4A and DDB1 associate with Skp2 to induce proteolysis of
p27 [32].
To assesswhether Skp2-independent degradation of p27detected in
Cdk2−/−Skp2−/− cells involved any of the aforementioned ubiquitin li-
gase complexes, we performed knockdown of KPC1, Pirh2, and DDB1.
Interestingly, the ablation of these ligases did not restore p27 stability
in Cdk2−/−Skp2−/− cells, indicating novel mechanisms for the regula-
tion of p27 in the absence of Skp2 and Cdk2.
2. Materials and methods
2.1. Mouse strains
The generation of Cdk2−/− [1] and Skp2−/− [18] mice has been
described previously. Cdk2+/−Skp2+/− double heterozygotes mice
were generated by crossing Cdk2+/− (C57BL/6 and 129S1/SvImJ
mixed background) and Skp2+/− mice (C57BL/6 and 129S1/SvImJ
mixed background). Double heterozygotes were then intercrossed to
generate wild type (WT), Cdk2−/−, Skp2−/−, and Cdk2−/−Skp2−/−
(DKO) mice.
2.2. Isolation and culture of primary MEFs
PrimaryMEFswere isolated fromE13.5mouse embryos as described
previously [1]. Brieﬂy, the head and the visceral organs were removed,
the embryonic tissue was chopped into ﬁne pieces with a razor blade
and trypsinized for 15 min at 37 °C, and ﬁnally tissue and cell clumps
were dissociated by pipetting. Cells were plated in a 10 cm culture
dish (passage 0) and grown in DMEM (12701-017; Invitrogen) supple-
mentedwith 10% FCS (26140; Invitrogen) and 1% penicillin/streptomycin
(15140-122; Invitrogen). Primary MEFs were cultured in a humidiﬁed
incubator at 5% CO2 and 21% O2.
2.3. Histology and immunohistochemistry
Five week old mice were injected intraperitoneally with the
cell proliferation labeling reagents (10 μg per 10 g body weight)
bromodeoxyuridine (BrdU) and ﬂuorodeoxyuridine (FdU) [RPN201;
GE Healthcare/Amersham Biosciences] 3 h before euthanasia. Testes
were collected and ﬁxed in 4% paraformaldehyde or Bouin's ﬁxative be-
fore histological processing. Testes sections (ﬁxed in Bouin's ﬁxative)
were stained with PAS-hematoxylin (PAS-H). Testes sections (ﬁxed in
4% paraformaldehyde) were stained with antibodies against BrdU
(B35138; Invitrogen) to detect proliferating cells. Livers from 4 month-
old mice were ﬁxed in 10% neutral buffered formalin (HT501128;
Sigma). Liver sections were stained with hematoxylin-eosin (HE) or
Feulgen's solution.2.4. Cell culture and FACS analysis
Senescent cells were detected by staining for SA-β-galactosidase
[33]. Primary MEFs were seeded in a 6 well dish, washed the next day
with PBS two times and incubated for 5 min in ﬁxative solution [2%
(wt/vol) formaldehyde/0.2% (wt/vol) glutaraldehyde solution in PBS].
Cells were then incubated overnight at 37 °C in staining solution
[20 mM citric acid, 40 mM Na2HPO4 pH 6.0, 150 mM NaCl, 5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl2,
1 mg/mL X-Gal; 15520034; Invitrogen], and visualized for blue color
staining.
For 3T3 assays, 300,000 primary MEFs were plated in 10 cm dishes.
Every 3 days, cells were trypsinized and counted, followed by replating
of 300,000 cells [34]. For proliferation assays, 1500 cells were plated in
96-well plates in ﬁve replicates. Proliferation rates were determined
by measurement of metabolic activity every 24 h by incubating cells
for 4 h in 150 μl of detection reagent [Alamar Blue (BUF012B; AbD
Serotec) diluted 1:10 in growth medium], and measuring ﬂuorescence
at 590 nm.
For cycloheximide pulse-chase analyses, 2 million cells were
plated in a 15 cm dish and grown for 24 h, followed by treatment
with 50 μg/ml of cycloheximide for 0, 2, 4, or 6 h. Control cells
were treated with DMSO or a combination of cycloheximide (50 μg/ml)
and MG132 (10 μM) for 6 h. Cells were harvested and processed for
immunoblotting.
The silencing of Cdk2 was performed by infection of MEFs with ret-
roviral shRNA construct pMKO.1-shCdk2C kindly provided by Piotr
Sicinski. The silencing of KPC1 was performed by infection of MEFs
with retroviral shRNA construct pMX-puro II-shKPC1-1 [21]. shRNA se-
quences for targeting Pirh2mRNA (shPirh2-1 and shPirh2-2) have been
reported previously [28]. The other shRNA sequences for targeting Pirh2
mRNA (shPirh2-3: 5′ACCAAUGAAGAUCAUCAGC3′ and shPirh2-4:
5′CUAGAUCGUUUCAAAGUCA3′) as well as shRNA sequences for
targeting DDB1 mRNA (shDDB1-1: 5′CCUGUAUCUU GGAGUAUAA3′,
shDDB1-2: 5′CCUAACUUAUCUUGAUAAU3′, shDDB1-3: 5′GCCCAU
CAGUUUCUACAAA3′, shDDB1-4: 5′CACUACAACAACAUCAUG3′) were
predicted by OligoEngine 2.0 software (for Pirh2-3 and DDB1-4) and
siDirect website (http://sidirect2.rnai.jp/) (for Pirh2-4, DDB1-1, DDB1-2
and DDB1-3). shRNA sequence speciﬁc for EGFP (Clontech) mRNA (5′
GCUGACCCUGAAGUUCAUC3′) was used as a control. Oligonucleotides
were cloned into the pSUPER.retro.puro retroviral vector (OligoEngine)
and MEFs were infected as described previously [35].
To prepare single cell suspensions from liver, small pieces of liver
were passed through a 3 ml syringe plunger ﬁtted with a 40 μm nylon
mesh and the resulting cell suspension was again passed through
another 40 μm nylon mesh Cell Strainer (352340; BD Biosciences).
Cells were stained with propidium iodide and FACS analysis was per-
formed using a FACS Calibur ﬂow cytometer (BD Biosciences). Resulting
data was analyzed using the FlowJo 8 software.
2.5. Western blot analysis, immunoprecipitation, and kinase assays
Lysates from MEFs were prepared as described previously [35] and
used for Western blots or kinase assays. The following antibodies were
used in this study: cyclin A2— Santa Cruz Biotechnology#SC-596, cyclin
B1 — Cell Signaling #4135, cyclin D1 — Lab Vision #RB-010-P, cyclin
E1— eBioscience #14-6714-63, Cdk1 & Cdk2 as described [1], Cdk4—
Clontech #S1194, p16 — Santa Cruz Biotechnology #SC-1207, p21 —
Santa Cruz Biotechnology #SC-6246, p27— BD Biosciences #610242,
p53— Cell Signaling #2524, Skp2— Santa Cruz #SC-7164, KPC1 [21],
Pirh2 — Santa Cruz Biotechnology #SC-46239X, DDB1 — Invitrogen
#34-2300, HSP90 — BD Biosciences #610418, Myc — Cell Signaling
#2278, Ubiquitin — Pierce #1859660, SV40-T — Merck # DP01L and
Rb— BDPharmingen #554436. For immunoprecipitation and kinase as-
says, cross-linked antibodies against Cdk2 and cyclin B1 [as described
in [35]], anti-Cdk1 (Santa Cruz #SC-54AC), anti-cyclin A2 (Santa Cruz
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Fig. 1. Silencing of Cdk2 leads to decreased proliferation and destabilization of p27 in Skp2−/− MEFs. (A) WT and Skp2−/− MEFs were infected with retroviruses encoding for
control or Cdk2 shRNA. Proliferation rates of unsynchronized MEFs at passage 4 were analyzed using alamarBlue assays. The numbers in (A) are average values from 3 indepen-
dent experiments. The value obtained on day 1 was set to 1, and values on following days were normalized accordingly. (B) β-galactosidase staining was performed following
Cdk2 knockdown to determine senescence in Skp2−/−MEFs. The graph depicts the percentage of senescent cells at passage 4 in WT and Skp2−/−MEFs with 300 cells counted
per genotype. The percentages of senescent cells are average values from two independent experiments. (C)Whole cell extracts of WT and Skp2−/−MEFs after Cdk2 knockdown
was analyzed by Western blotting using antibodies against cyclin A2, cyclin E1, Cdk1, Cdk2, p16, p21, p27, p53, Skp2, and HSP90 (loading control). Unspeciﬁc bands are marked
as *. Extracts were immunoprecipitated with suc1 (that binds to Cdk1 and Cdk2), or antibodies against cyclin A2, cyclin B1, and Cdk4. The immunoprecipitated protein com-
plexes were probed with antibodies against cyclin A2, cyclin B1, cyclin D1, cyclin E1, Cdk1, Cdk2, Cdk4, p27, or p21. MEFs infected with control vector are depicted on the left
(lanes 1 and 2) and shCdk2 treated cells on the right (lanes 3 and 4). (D) Destabilization of p27 following Cdk2 knockdown in Skp2−/− MEFs was determined by treating WT
and Skp2−/− MEFs at passage 4 with cycloheximide for 2, 4, and 6 h. Western blot analysis was performed on these cell extracts using antibodies speciﬁc for p27, Cdk2,
Skp2, or HSP90 (loading control). (E) p27 bands in (D)were quantiﬁed using the ImageJ software. The value for 0 hwas set as 100% and other time points were expressed relative
to it.
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Table 1
Mendelian ratio of progeny derived from Cdk2+/−Skp2+/− intercrosses.
Progeny Observed (%) Expected (%)
WT 27 7.9 6.25
DKO 8 2.3 6.25
Cdk2−/− 20 5.8 6.25
Skp2−/− 12 3.5 6.25
Cdk2+/−Skp2+/− 95 27.6 25
Cdk2+/−Skp2+/+ 72 20.9 12.5
Cdk2+/−Skp2−/− 22 6.4 12.5
Cdk2+/+Skp2+/− 46 13.4 12.5
Cdk2−/−Skp2+/− 42 12.2 12.5
Total 344 100 100
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(Millipore #14-132) were used.
2.6. Immunoﬂuorescence microscopy
200,000 MEFs were plated in 12-well plates containing poly-D-
lysine-coated coverslips. The next day, cells were washed 3 times
with PBS and ﬁxed in ice-cold methanol for 6 min. This was followed
by 3 washes with PBS and permeabilization in PBS with 0.25% TritonX-
100 (PBST) for 3 min. Cells were then blocked for 1 h in PBST with 2%
BSA (blocking buffer), followed by one wash with PBST containing 1%
BSA (wash buffer). Coverslipswere incubated for 2 h at 37 °C in a humid-
iﬁed chamber in blocking buffer containing 1:500 anti-gamma Tubulin
antibody (AbcamGTU88#ab11316) and 1:500 anti-pericentrin antibody
(Covance #PRB-432C). Following 3 washes with wash buffer and 1 h in-
cubation at 37 °Cwith Alexa Fluor conjugated secondary antibodies, cov-
erslips were counterstained with DAPI and mounted onto slides using
Immuno-mount (Thermo Scientiﬁc #9990402).
2.7. Polysome proﬁling
Polysome fractionations were performed as described with the fol-
lowing modiﬁcations [36]. 10 million cells were incubated with
100 μg/mL of cycloheximide for 10 min. The cell pellets were resus-
pended in 125 μl 2× RSB buffer (20 mM Tris–HCl, pH 7.4, 300 mM
NaCl, 30 mM MgCl2, 200 μg/mL cycloheximide, 1 U/μl SUPERase.In™
RNase inhibitor, Life Technologies # AM2696), and then lysed with 2×
lysis buffer (20 mM Tris–HCl, pH 7.4, 20 mM NaCl, 300 mMMgCl2, 1%
Triton X-100, 2% Tween-20, 1% deoxycholate). Following centrifugation
to remove nuclei, supernatants were loaded onto 10% to 50% linear
sucrose gradients and centrifuged at 36,000 rpm for 60 min at 8 °C
in an SW60 rotor (Beckman Coulter). 6 fractions were collected, SDS
was added to a ﬁnal concentration of 1% and 6 μl of proteinase K
(10 mg/mL Invitrogen) was added to each fraction and incubated for
30 min at 42 °C. RNAwas puriﬁed by 2x Phenol Chloroform Isoamyl ex-
traction, once by chloroform isoamyl extraction followed by ethanol
precipitation. Affymetrix Genechip spike-in poly A RNAs (Ambion
#900433)were added to each fraction in equal amounts. cDNAwas syn-
thesized from equal volumes of RNA from each fraction using a reverse
transcription kit (Superscript III, Invitrogen) according to the
manufacturer's instruction. For RT-PCR, SYBR Green was used with
gene speciﬁc primers on an ABI PRISM 7900 Sequence Detection Sys-
tem. Values for p27 and GAPDH were normalized to THR. Sequences
of primers (5′ to 3′) used for real-time PCR are as follows; p27 fwd:
GAAATCTCTTCGGCCCGGTC, p27 rev: CACTTGCGCTGACTCGCTTC,
GAPDH fwd: TGCACCACCAACTGCTTAGC, GAPDH rev: GGCATGGACT
GTGGTCATGAG, THR fwd: CTCGCTCAAGCTGTCATGTAC, THR rev:
CGGTGATTTCTCACAGATGG.
2.8. RT-PCR analysis
Total RNA from MEFs was extracted using the RNeasy Mini Kit
(QIAGEN). 2.5 μg of total RNA from MEFs was reverse transcribedusing SuperScript VILO cDNA Synthesis Kit (11754250; Invitrogen).
Quantitative real-time PCR was performed using Maxima SYBR
Green qPCR Master Mix (2×) (K0252; Fermentas) with a Rotor
Gene 6000 PCR machine (Corbett Research). Sequences of primers
(5′ to 3′) used for real-time PCR are as follows; p27 fwd: GAAATC
TCTTCGGCCCGGTC, p27 rev: CACTTGCGCTGACTCGCTTC, Actin fwd:
ACGGCTCCGGCATGTGCAAA, Actin rev: TTCCCACCATCACACCCTGG,
Hsp90 fwd: ACTGCTCTGCTCTCCTCTGG, Hsp90 rev: CATCGATGCCCA
GGCCTAGT.
2.9. Ubiquitination assay
Passage 2 MEFs were infected with retroviral construct pMC-Myc-
Puro-p27 and treated with DMSO or 10 μMMG132 for 6 h. MEFs were
then lysed in RIPA buffer (50 mM Tris–HCl pH 7.4, 0.5% NP-40, 1%
sodium deoxycholate, 0.1% SDS, 150 mM NaCl) supplemented with
10 mM β-glycerophosphate, 10 μM α-iodoacetamide (freshly pre-
pared), 1 mM DTT, 0.1 mM PMSF, 0.1 mM sodium orthovanadate
and 20 μg/ml each of leupeptin, pepstatin and chymotrypsin.
Lysates containing 1 mg of total protein were subjected to immu-
noprecipitation overnight at 4 °C using anti-Myc agarose beads in
modiﬁed RIPA buffer (50 mM Tris–HCl pH 7.4, 0.5% NP-40, 1%
sodium deoxycholate, 150 mM NaCl) supplemented with 10 mM
β-glycerophosphate, 10 μM α-iodoacetamide (freshly prepared),
and 10 μg/ml each of leupeptin, pepstatin, and chymotrypsin. The
anti-Myc immunoprecipitates were washed three times in modi-
ﬁed RIPA buffer supplemented with 10 mM β-glycerophosphate,
1 μM α-iodoacetamide (freshly prepared), and 10 μg/ml each of
leupeptin, pepstatin, and chymotrypsin. Following elution at 95 °C for
5 min in SDS/PAGE sample buffer, protein complexes were resolved
on 4–15% gradient polyacrylamide gels and transferred onto PVDF
membranes using a semi-dry system. Blots were probed with anti-
Myc or anti-ubiquitin antibodies.
3. Results and discussion
3.1. Silencing of Cdk2 in Skp2−/−MEFs leads to destabilization of p27 and
impaired proliferation
Cdk2 has been previously reported to be dispensable formitotic pro-
gression [1,2]. In the absence of Cdk2, Cdk1 regulates S phase progres-
sion resulting in nearly normal cell cycle progression [3,4]. To test the
functions of Cdk2 more rigorously, we decided to use Skp2−/− cells
with the premise that high levels of p27 in these cells would inhibit
Cdk1 activity. The knockdown of Cdk2 in Skp2−/−MEFs led to senes-
cence and abrogated proliferation (Fig. 1A–B), indicating essential
roles of Cdk2 under conditions of reduced Cdk functionality. As expect-
ed from the premature onset of senescence in these cells, the expression
of cell cycle regulators such as cyclin A2 and Cdk1 was signiﬁcantly de-
creased, as was their interaction with corresponding cyclin or Cdk part-
ners, and p21 (Fig. 1C). The expression of cyclin E1 that is known to
accumulate in Skp2−/−MEFs was also reduced upon Cdk2 knockdown,
whereas the expression of cell cycle inhibitory proteins p16, p21,
and p53 remained unchanged. Surprisingly, the depletion of Cdk2 in
Skp2−/− MEFs led to lower p27 protein levels, as well as decreased
interaction of p27with cyclin A2, Cdk4, and Cdk1 (Fig. 1C). This was un-
expected, since we assumed the increased p27 levels in Skp2−/−MEFs
to result in increased p27/Cdk1 interactions which would inhibit Cdk1
in the absence of Cdk2. Unlike Skp2−/− MEFs where p27 stability is
enhanced, the knockdown of Cdk2 in Skp2−/−MEFs resulted in destabi-
lization of p27, similar to control cells (Fig. 1D). Thus, the depletion of
Cdk2 in Skp2−/− cells led to an overall inactivation of the cell cycle
machinery and senescence, but restored p27 turnover to normal rates
(Fig. 1E), indicating the regulation of p27 stability by Skp2-independent
pathways in the absence of Cdk2.
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Fig. 2. Cdk2−/−Skp2−/− double knockout mice are viable with reduced body and organ size. (A) Representative male wild type (WT), Cdk2−/−Skp2−/− (DKO), Skp2−/−, and Cdk2−/−
mice at 5 week of age are shown along with testis, thymus, and spleen. Scale bar: 5 mm. (B, C) Body weight increase was plotted for for male (B) and female (C) WT, DKO,
Skp2−/−, and Cdk2−/− mice. (D–S) Histological analysis of testis (D–K) and liver (L–S) of WT (D, H, L and P), DKO (E, I, M and Q), Skp2−/− (F, J, N and R), and Cdk2−/− (G, K,
O and S) mice. (D–K) Mice in (A) were pulse labeled with BrdU. They were euthanized 3 h after injection and sections of the testis were stained with PAS-hematoxylin solutions (D–
G) or processed for immunostaining with antibodies against BrdU (H–K). Scale bars: 50 μm. (L–S) Nuclear enlargement and polyploidy in livers of DKOmicewas determined by staining
of 4 month old male mouse liver sections with hematoxylin-eosin (L–O) or with Feulgen solution (P–S). Scale bars: 25 μm. (T–W) Flow cytometric analysis of the DNA content of hepa-
tocytes from mice in (L–S), representative of 2 independent experiments.
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Since Cdk2 knockdown in Skp2−/− cells revealed important roles of
Cdk2 in cell proliferation, we generated Cdk2−/−Skp2−/− double
knockout (DKO) mice to ascertain these ﬁndings in vivo. DKO miceA B
C
E
Fig. 3. Analysis of Cdk2−/−Skp2−/− double knockout MEFs. (A) Proliferation rates of passage 2
dependent experiments. The value obtained on day 1 was set to 1, and values on following day
tocol. Cumulative cell numberswere plotted for eachMEF line. The graph is representative of 3–
byWestern blotting using antibodies against cyclin A2, cyclin D1, cyclin E1, Cdk1, Cdk2, Cdk4, p1
Whole cell extracts in (C) were immunoprecipitated using antibodies against cyclin A2, Cdk2, C
lyzed byWestern blotting for changes in levels of the binding partners cyclin A2, cyclin B1, cycli
suc1 (suc1 binds to Cdk1 and Cdk2), and antibodies against cyclin A2, cyclin B1, Cdk1 andCdk2.
ATP and histone H1 as substrate. Data in C–D is representative of 3 independent experiments awere viable but were born below Mendelian ratio, similarly as
Skp2−/− mice (Table 1). The decreased organ size seen in Skp2−/−
mice was also observed in DKO mice. The size of thymus and spleen
in DKO was similar to Skp2−/−mice, while the testes of DKO mice was
signiﬁcantly smaller than Skp2−/− andCdk2−/−mice (Fig. 2A). Size andD
MEFs were determined by alamarBlue assays. The graph depicts average values from 3 in-
s were normalized accordingly. (B) MEFs were immortalized using the 3T3 passaging pro-
4 MEF clones (as indicated in ﬁgure) per genotype. (C)Whole cell extracts were analyzed
6, p21, p27, p53, Skp2, andHSP90 (loading control). Unspeciﬁc bands aremarked as *. (D)
dk4, and suc1 beads (suc1 binds to both Cdk1 and Cdk2). Immunoprecipitates were ana-
n D1, cyclin E1, Cdk1, Cdk2, Cdk4, p21, or p27. (E) Extracts were immunoprecipitatedwith
Immunoprecipitateswere analyzed in vitro for associated kinase activity using radiolabeled
nd data in 3E is representative of 2 independent experiments.
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and female mice smaller compared to control littermates (Fig. 2B–C).
The sterility and testicular atrophy that have been described for
Cdk2−/− were also observed in DKO mice (Fig. 2D–K). Since liver in
Skp2−/− mice is severely affected with enlarged hepatocytes and
reduced cell number [18], we also assessed livers of DKO mice. The
phenotype of DKO livers was more pronounced with DKO hepatocytes
nuclei larger compared to Skp2−/− hepatocytes (Fig. 2P–S). The
increase in nuclear ploidy seen in Skp2−/− hepatocytes (up to 16 N
DNA content) was retained in DKO mice (Fig. 2T–W).
3.3. Cdk2−/−Skp2−/−MEFs proliferate with normal turnover of p27
To ascertain the roles of Cdk2 observed upon Cdk2 knockdown in
Skp2−/−MEFs, we generated MEFs from DKO embryos. Unexpectedly,
low passage DKO MEFs proliferated at rates comparable to control
MEFs and did not display any signiﬁcant impairment of proliferation
(Fig. 3A). Thus in contrast to the results obtained upon acute silencing
of Cdk2 in Skp2−/−MEFs, cells from DKO mice exhibit developmentalWT DKO
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Since Skp2−/− MEFs exhibit centrosome ampliﬁcation [18], we
determined whether the loss of Cdk2 affected centrosome numbers in
Skp2−/−MEFs which might contribute to the normal proliferation of
DKO MEFs. Similar to Skp2−/−MEFs, DKO MEFs exhibited centrosome
ampliﬁcation (Supplementary Fig. 1); thus normal proliferation of
DKO MEFs was not related to any alterations in centrosome numbers.
Repeated passaging of DKO MEFs using the 3T3 protocol revealed a
minor decrease in the growth rate (Fig. 3B) with DKO MEFs entering
senescence earlier than Skp2−/− or Cdk2−/−MEFs.
Detailed biochemical analysis revealed no signiﬁcant changes in ex-
pression of various cell cycle regulators or Cdk/cyclin complexes, with
the exception of cyclin E that was expressed at decreased levels com-
pared to Skp2−/−MEFs (Fig. 3C). Since we expected p27 to relocate to
and inhibit Cdk1 in the absence of Cdk2, we were surprised to ﬁnd
that Cdk1/p27 interactions were comparable between Skp2−/− and
DKO MEFs (Fig. 3D), as was Cdk1-associated kinase activity (Fig. 3E).
A small increase in the binding of p27 to Cdk4 was observed in the
DKO MEFs when compared to Skp2−/− MEFs (Fig. 3D). Importantly,Skp2-/- Cdk2-/-
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443S. Kotoshiba et al. / Biochimica et Biophysica Acta 1843 (2014) 436–445the elevated p27 expression in Skp2−/−MEFs was equally elevated in
DKO MEFs (Fig. 3C). However, the increased expression did not trans-
late to enhanced stability since cycloheximide pulse-chase analysis re-
vealed that unlike in Skp2−/− cells where p27 displays heightened
stability, DKO cells exhibited normal turnover of p27 that was compara-
ble to Cdk2−/− and wild type MEFs (Fig. 4A–B). Because p27 mRNA
levelswere comparable betweenWTandDKOMEFs (Fig. 4C),we exam-
ined whether the destabilization of p27 upon Cdk2 deletion in Skp2−/−
MEFs may be due to differences in Rb/E2F-mediated transcriptional
regulation of p27. To this end, we expressed SV40-T antigen in MEFs
to inhibit Rb-mediated sequestration of E2F and observed increased
proliferation of DKO MEFs (Fig. 5A), suggesting that transcriptional
regulation of p27 may contribute to the destabilization of p27 in the
absence of Cdk2 and Skp2. SV40-T expression did not change levels of
p27 in MEFs, but led to increased levels of cell cycle regulators cyclin
A2, cyclin B1, cyclin E1, Cdk1, and p53 (Fig. 5B).
It was surprising that p27 expression was increased in DKO MEFs
despite comparable half-life to wild type MEFs. We speculated that
the regulation of p27 translation might contribute to its increased
expression in DKOMEFs. To this end, we performed polysome fraction-
ation of MEFs and quantitated the amount of p27mRNA in the fractions10
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mRNA in WT MEFs compared to Cdk2−/− , Skp2−/− , and DKO MEFs,
but no signiﬁcant differences were observed between Cdk2−/− ,
Skp2−/− , and DKO MEFs (Supplementary Fig. 2). We also assessed
the levels of HuR, a member of the Hu protein family of RNA binding
proteins that is known to regulate internal ribosomal entry site
(IRES)-dependent translation of p27 [37], but HuR protein expression
in DKOMEFswas comparable to wild typeMEFs (data not shown). Pos-
sibly, other translational regulatory pathways may target p27 in DKO
cells [38,39]. Finally, in addition to MEFs, we also observed increased
p27 expression in thymus isolated from DKO mice (data not shown),
suggesting a role for Skp2-independent regulation of p27 in the absence
of Cdk2 in other cell types.
3.4. Ubiquitin ligases KPC1, Pirh2, DDB1 do not regulate p27 in
Cdk2−/−Skp2−/− cells
In order to examinewhether p27 is regulated by ubiquitin-mediated
proteasomal degradation in DKO MEFs, we expressed Myc-tagged p27
in MEFs, followed by immunoprecipitation with antibodies against the
Myc-tag andWestern blot for p27 andubiquitin. Increased ubiquitination10
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ing that p27may be regulated by ubiquitin-mediated proteasomal deg-
radation in the absence of Cdk2 and Skp2 (Supplementary Fig. 3).
Next, we decided to examinewhether three known ubiquitin ligases
for p27; KPC1, Pirh2, and the DDB1-Cul4 complex contributed towards
destabilization of p27 in Cdk2−/−Skp2−/−MEFs. Since KPC1 and Skp2
function at different phases in the cell cycle (G0/G1 and S/G2, respec-
tively), we also studied p27 stability in DKO MEFs that were synchro-
nized and saw a similar destabilization of p27, indicating an active
KPC1 pathway in DKO cells (data not shown). The shRNA construct
used for knockdown of KPC1 has been previously validated by us [21]
We designed four shRNA constructs each for knockdown of Pirh2 and
the DDB1-Cul4 complex, and chose one construct each that proved
most efﬁcient in knockdown (Fig. 6A) for the assessment of p27 turn-
over. Individual knockdown of KPC1, Pirh2, and theDDB1-Cul4 complex
did not restore stability of p27 in Cdk2−/−Skp2−/−MEFs (Fig. 6B,D).We
also attempted to knockdown these ubiquitin ligases in combination.
The steady state levels of p27 did not change signiﬁcantly followingknockdown of two or all three ligases (Fig. 6C). Our results suggest
that KPC1, Pirh2 or DDB1-Cul4 do not mediate the degradation of p27
in Cdk2−/−Skp2−/− cells. Therefore, it is possible that novel ubiquitin li-
gases for p27 are awaiting identiﬁcation.
In summary, we have shown that Skp2−/−Cdk2−/− DKO mice are
viable and display similar phenotypes as Cdk2−/−and Skp2−/−
mice. The most interesting result was that although p27 is stabilized
in Skp2−/− cells, it is not stabilized in DKO cells. This indicates that
the stability of p27 in Skp2−/− cells is dependent on the presence of
Cdk2. The role of Cdk2 could be to target p27 directly via phosphoryla-
tion or indirectly by inﬂuencing the activity of E2F or substrate speciﬁc-
ity of the ubiquitin ligase. We have demonstrated that p27 binds more
prominently to Cdk4 in the absence of Cdk2 suggesting that p27
bound to Cdk4 is a better substrate than p27/Cdk2. It is possible that
the phosphorylation status of p27 differs when in complex with Cdk4
or Cdk2. Alternatively, the binding afﬁnities of p27 to Cdk4 or Cdk2
may vary. We have also shown that p27 can be degraded independent
of Skp2/KPC1/Pirh2/DDB1 suggesting that novel E3 ligases of p27 may
445S. Kotoshiba et al. / Biochimica et Biophysica Acta 1843 (2014) 436–445await discovery. It seems likely that Skp2/KPC1/Pirh2/DDB1 are the pre-
dominant ligases responsible for targeting p27 under most conditions,
but we cannot exclude that there are cells, tissues, or conditions
where other E3 ligases will target p27 in vivo. Future studies will need
to focus on the identiﬁcation of such E3 ligases and their physiological
relevance.
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